SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$93.19
Tradestie Score
56
Market Cap
$994.20M
Analyst Upside
+29.0%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECH
Bio-Techne Corp.
|
$72.40
|
$9.33B | 62.4 | 62 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$116.23
|
$8.88B | 259.1 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$109.86
|
$8.77B | 32.4 | 54 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$206.64
|
$8.57B | - | 53 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$28.30
|
$8.53B | 3.2 | 38 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$235.67
|
$8.30B | 15.9 | 67 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$65.60
|
$6.68B | - | 63 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$92.83
|
$6.64B | - | 46 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$92.88
|
$6.38B | - | 67 | Compare |
More SYRE Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry